SCHEMBL14013167

SCHEMBL14013167

COc1ccc(NC(=O)c2c(N)cc(OC)cc2OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.54
▸ RAB9A P51151 8/20 0.54
▸ SMN1; SMN2 Q16637 7/20 0.54
▸ TP53 P04637 4/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.52
▸ GAA P10253 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ HDAC8 Q9BY41 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ CISD2 Q8N5K1 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ HDAC1 Q13547 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12799393 0.93 NPC1 (0.46) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL1663386 0.91 MEN1 (0.51) NPC1SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL14176439 0.85 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL11303092 0.84 CYP3A4 (0.60) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL14176438 0.83 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL14176435 0.81 MAPT (0.56) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL10962287 0.81 NPC1 (0.51) NPC1RAB9ASMN1; SMN2TP53ALOX15
SCHEMBL14176441 0.80 MAPT (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL14176440 0.80 ABCB1 (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL31710349 0.79 MEN1 (0.60) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456188-B1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 — — US disclosed
Send feedback